Understanding how small molecules interface with amyloid fibrils at the nanoscale is of importance for developing therapeutic treatments against amyloid-based diseases. Here, we show for the first time that human islet amyloid polypeptides (IAPP) in the fibrillar form are polymorphic, ambidextrous, and possess multiple periodicities. Upon interfacing with the small molecule epigallocatechin gallate (EGCG), IAPP aggregation was rendered off-pathway and assumed a form with soft and disordered clusters, while mature IAPP fibrils displayed kinks and branching but conserved the twisted fibril morphology. These nanoscale phenomena resulted from competitive interactions between EGCG and the IAPP amyloidogenic region, as well as end capping of the fibrils by the small molecule. This information is crucial in delineating IAPP toxicity implicated in type 2 diabetes and for developing new inhibitors against amyloidogenesis.
Introduction
Protein misfolding and aggregation, regardless of culprit origin and sequence, are a ubiquitous phenomenon in neurodegenerative diseases and type 2 diabetes (T2D) that is characterized by the formation of a cross-β architecture common to all amyloid fibrils and plaques [1] [2] [3] . Naturally occurring small molecules, Nano Res. 2018, 11 (7) : 3636-3647 such as curcumin, resveratrol, epigallocatechin-3-gallate (EGCG), orcein, and 2,8-bis-(2,4-dihydroxy-phenyl)-7-hydroxy-phenoxazin-3-one (O4), as well as synthetic polymers and nanoparticles have shown potency in directing the progression of β-amyloids, α-synucleins, islet amyloid polypeptides (IAPP), prions, and cystatin amyloids towards disordered and amorphous aggregates [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Modifications of the dihydrothiazolo ring-fused 2-pyridones effectively interrupted curli biogenesis of Escherichia coli and prevented biofilm formation [16] . However, nanoscale properties of amyloid inhibition by small molecules remain unclear, hindering the design of new inhibitors targeting amyloidogenesis.
EGCG possesses modest water solubility (33.3-100 g/L) and a high capability of remodeling amyloid fibrils [17] . EGCG redirected the fibrillogenesis of both β-amyloid and α-synuclein into unstructured, non-toxic, off-pathway oligomers [18] , and remodeled mature amyloid-β and α-synuclein into smaller, amorphous protein aggregates that were non-toxic [5] . EGCG remodeled IAPP amyloid fibrils but did not fully resolubilize them back to monomers, suggesting that IAPP fibrillization and EGCG remodeling are irreversible processes [19] . A mutation study revealed that the interactions of EGCG with aromatic residues, amino groups, and sulfhydryls of IAPPs were nonessential for amyloid inhibition and remodeling, pointing to the roles of hydrogen bonding and hydrophobic interactions between the small molecule and the peptide backbone and side chains, respectively [19] . EGCG inhibition of IAPP amyloids and protection against IAPP toxicity was investigated [20] , revealing an on-pathway EGCG trapping of the polypeptide into an early intermediate state prior to IAPP amyloid formation. When the role of EGCG autoxidation in the remodeling of amyloid-β , IAPP [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] , or Sup35NM Ac7-16 Y→F amyloid fibrils was examined [21] , the importance of hydrophobic interactions for such interactions was highlighted. EGCG displayed a reduced capacity in inhibiting IAPP aggregation in the presence of a DPPG lipid monolayer, suggesting the competing role of interfaces with IAPP-small molecular interactions [22] .
In the present study, we combined transmission electron microscopy (TEM), atomic force microscopy (AFM), and discrete molecular dynamics (DMD) simulations to extract nanoscale information on IAPP inhibition and remodeling by fresh, autoxidized, or glutathione (GSH)-reduced EGCG. We systematically analyzed the persistence length, contour length ( Fig. 1(a) and Fig. S5 in the Electronic Supplementary Material (ESM)), as well as the morphology of IAPP and IAPP-EGCG products versus time. We report on the polymorphic and ambidextrous nature of IAPP fibrils and reveal the molecular details of EGCG interacting with soluble IAPP and insoluble IAPP fibrils using DMD simulations, a rapid sampling technique for depicting large systems with atomic information. The nanoscale information uncovered by this study has filled a knowledge gap between the atomic-and cellular-level understanding of IAPP amyloidogenesis and mitigation against type 2 diabetes.
Results and discussion

Nanoscale IAPP interfacing with EGCG
TEM imaging revealed IAPP fibrillization in the presence of EGCG and its derivatives. Representative images of the 20 min incubation are shown in Fig. S1 in the ESM; however, they were not analyzed owing to the small sizes of IAPP and IAPP-EGCG protofibrils. The selection of 1, 6, and 24 h of fibrillization was intended to cover nucleation, end of elongation, and saturation phases ( Fig. 1(b) ), respectively.
IAPP seeds and protofibrils (30-200 nm) emerged after 1 h for IAPP alone and IAPP with fresh, oxidized, or GSH-reduced EGCG. In the presence of EGCG, the protofibrils appeared amorphous with multiple splitting branches (Figs. 1(f), 1(i), and 1(l)), differing from the linear contours of the IAPP control ( Fig. 1(c) ). After 6 h, IAPP formed long fibrils ( Fig. 1(d) ) with a broad length distribution (160-17,400 nm; Fig. 2(a) ), whereas EGCG yielded short and ramified fibrils (Figs. 1(g), 1(j), 1(m) and 2(b)-2(d)). Fibrillization inhibition was achieved with fresh EGCG at 6 h (contour length, 65-330 nm; Figs. 1(g) and 2(b)), whereas oxidized EGCG rendered longer fibrils (40-1,125 nm; Figs. 1(j) and 2(c)). At 24 h, IAPP length distribution was further broadened (60-20,600 nm; Fig. 2(a) ), and all samples displayed polymorphisms of long fibrils alongside Nano Res. 2018, 11(7): 3636-3647 short, soft, and curvy fibrils/protofibrils. Such heterogeneity of IAPP fibrils was also observed by vandenAkker et al. [23] using tip-enhanced Raman spectroscopy, where unordered or α-helical surface structures contrasted the β-sheet rich fibril core. Coexistence of amyloid and non-amyloid fibrils have also been reported for other classes of proteins in vitro [24] . Further analysis revealed that long IAPP fibrils were 7.9 (± 0.9) nm in thickness, whereas short ones were 9.8 (± 2.5) nm in thickness with more pronounced variations due to their amorphous nature ( Fig. 1(e) , inset). In addition, short fibrils re-emerged at 24 h ( Fig. 2(a) , yellow circle), departing from the log-normal distribution of such aggregation processes [25, 26] and corroborating the possibility of multiple fibrillation rates for IAPP. No small fibrils were observed after one month ( Fig. 3(f) ).
Fresh, autoxidized, and GSH-reduced EGCG inhibited IAPP fibrillization up to 6 h ( Figs [20] . In the present study, fresh EGCG exerted stronger inhibition than oxidized EGCG up to 6 h. At 24 h, both fresh and oxidized EGCG displayed similar length distributions while GSH-reduced EGCG inhibited IAPP fibrillization more effectively. This is likely due to the gradual oxidation of fresh EGCG, as indicated by its color change after 6 h, and at 24 h, the initially fresh and autoxidized EGCG elicited similar inhibition. With GSH-reduced EGCG, shorter and fewer IAPP fibrils were observed than with other EGCG species. FiberApp [27] analysis confirmed a narrower length distribution in the case of GSH-reduced EGCG ( Fig. 2(d) ). Persistence length (λ) analysis [27, 28] using FiberApp revealed 3 distinct fibril species with reduced EGCG (Fig. 2(e) ), whereas the other samples displayed the formation of two different species-long and rigid fibrils and short and soft fibrils or amorphous aggregates. Accordingly, after 24 h in the presence of fresh, oxidized, or GSH-reduced EGCG species, the β-sheet content of IAPP was reduced from 39.2% to 34.3%, 35.7%, and 32.9%, respectively, while the unordered structure content was enhanced from 37.3%, as seen in the IAPP control, to 49.7%, 47.3%, and 51.7%, respectively (Figs. 2(f) and Fig. S2 in the ESM).
Fibrils that formed after 1 h were significantly softer (λ = 50-118 nm) than the long fibrils (λ = 2,020-2,885 nm) formed after 24 h. This difference in rigidity may stem from the ongoing elongation and self-assembly of proto-filaments/fibrils into amyloid fibrils (Figs. 3(a)-3(c)) [28, 29] . Twisted fibrils with a defined periodicity were observed at 6 h ( Fig. 3(a) ). ), similar to β-lactoglobulin [28] , lysozymes [30] , or β-amyloids [31] , suggesting a linear growth of primary filaments followed by lateral aggregation into mature amyloids.
Increasing the molar ratio of fresh EGCG to IAPP from 1:1 to 5:1 minimized long fibrils and increased curly aggregates after 6 and 24 h (Fig. S3 in the ESM). Persistence lengths of curly aggregates were 102 and 123 nm for the two conditions, consistent with that of IAPP exposed to equal molar ratios of fresh, autoxidized, or reduced EGCG (Fig. 2(e) ) due to effective aggregation inhibition.
EGCG possesses a remarkable capability in amyloid remodeling. Shortening of 1-month-old fibrils was evident after overnight incubation with EGCG ( Fig. 3(g) ).
However, despite such significant length reductions, twisted structures of IAPP fibrils remained largely unaltered upon EGCG exposure ( Fig. 3(g) ), suggesting that EGCG cleaved off amyloid fibrils but did not alter their morphology. In addition, average pitch sizes of 1-month-old fibrils remained unchanged, without EGCG, when evaluated by the autocorrelation function ( Fig. 3(i) ).
Molecular details of IAPP-interfacing EGCG
EGCG interfacing with soluble IAPP
We performed all-atom DMD simulations with 1, 2, 4, 6, and 8 IAPP peptides in the presence of EGCG (ligand), where the molecular ratio of EGCG to IAPP was kept at 1:1 and the same peptide concentration was maintained. In all simulations, we observed binding of EGCG with IAPP ( Fig. 4 and Fig. S4 in the ESM). EGCGs were bound to each other or to the peptide, while the peptides continued to grow in number of contacts (Fig. 4(c) ). Peptides and ligands often formed a single cluster (Fig. 4(a) ). Examinations revealed that EGCG ligands formed small clusters themselves and scattered inside the amorphous aggregates of both peptides and ligands (Fig. 4(b) ). In some simulations, inter-peptide β-sheets were formed (Fig. 4(b) ). The structural properties of these IAPP-EGCG complexes are drastically different from those of complexes between IAPP and resveratrol or curcumin [12] . For resveratrol and curcumin, hydrophobic ligands aggregated into a nanosized core, while IAPP peptides were bound to the surface by burying their hydrophobic residues and leaving hydrophilic residues Nano Res. 2018, 11 (7): 3636-3647 Nano Res. 2018, 11(7): 3636-3647 exposed; this formed a well-defined off-pathway oligomer that subsequently inhibits fibrillization. For EGCG, the small ligand clusters scattered inside the amorphous aggregates may not have prevented the continuous growth of aggregates, but instead interfered with the formation of an elongated fibril and resulted in the formation of curly aggregates (Figs. 1 and 2) . This difference likely originates from the higher solubility of EGCG compared with that of resveratrol or curcumin.
Residues R11, F15, H18, F23, and Y37 exerted significantly stronger binding with EGCG than with others ( Fig. 4(d) ). Since EGCG contains multiple benzene rings, the enrichment of aromatic IAPP residues in binding EGCG indicates that π-stacking is the driving force behind IAPP-EGCG interfaces. This finding is similar to that of our study on the off-pathway nanoassemblies of IAPP with curcumin and resveratrol [12] , where aromatic F15, F23, and Y37 residues were the most actively engaged in binding with small molecules. Nano Res. 2018, 11(7): 3636-3647
The strong binding of EGCG with R11 indicates the importance of hydrogen bonding.
EGCG interfacing with IAPP fibrils
Using solid-state NMR-derived constraints and two corresponding pentamer fibril models [32, 33] , we constructed larger fibril models with two decamer protofibrils forming a two-layered fibril (see Figs. 4 (e) and 4(f) for fibril Model 1, and Fig. S5 in the ESM for Model 2). EGCG tended to bind aromatic F15, F23, and Y37 residues of edge peptides and F15 and Y37 residues of interior peptides since F23 is buried inside the fibril; however, in simulations with fibril Model 2, EGCG bound to solvent-exposed F23 and Y37 of interior peptides instead (Fig. S5 in the ESM) . This is consistent with EGCG binding to soluble IAPPs (Figs. 4(a)-4(d) ). The pivotal role of π-stacking in assembly of tubular structures was established by Reaches and Gazit [34] , where β-amyloid diphenylalanine structural motifs readily assembled into discrete, hollow, and stiff nanotubes free of branching and curving. Here, the binding of EGCG to F23 of the end IAPP, which is otherwise buried inside the fibril, implies that EGCG binding may inhibit fibril growth. Moreover, EGCG molecules binding to fibril ends formed extensive contacts with the peptides (Figs. 4(e) and 4(g)), resulting in partial unfolding of peptides at the edges, while remaining peptides still formed β-sheets with the bulk fibril. Since fibrils undergo dynamic breakage and re-assembly [35] , remodeling of IAPP fibrils by EGCG is achieved by competitive binding with amyloidogenic residues at the fibril edges that are exposed upon thermodynamic breakage. Capping by EGCG prevented re-assembly into longer fibrils, leading to shorter fibrils with a preserved twisted morphology.
Oxidized EGCG interfacing with soluble IAPPs and IAPP fibrils
Oxidized EGCG was modeled after Theasinensin A (ThA), a cross-linked EGCG dimer ( Fig. 1(b) ) identified as a major product of EGCG auto-oxidization [36] . DMD simulations were performed for 2, 4, and 6 IAPP peptides mixed with ThA at a 2:1 ratio (i.e., a similar mass ratio to the simulations of EGCG and IAPP) and for binding of ThAs with the model IAPP fibril at the same molecular ratio. ThA displayed binding profiles similar to those displayed by IAPP residues in solution or in the fibril, and formed similar co-aggregated complexes with IAPPs as seen with EGCG (Fig. S7 in the ESM) . However, compared with that for EGCG, binding to soluble IAPP was slower due to the larger size of ThA and its slower diffusion rate. Consequently, EGCG tended to bind IAPP first before IAPP self-association (Fig. 4(c) and Fig. S4 in the ESM), but in the case of ThA, self-association of IAPP took place before ThA binding (Fig. S7(a) in the ESM). The slower binding of ThA with IAPP may have contributed to the reduced capacity of ThA in inhibiting IAPP aggregation, as observed experimentally.
Conclusion
IAPP fibrils displayed both left-and right-handed morphologies with different periodicities (Figs. 3(a)-3(e) ), unlike the morphologies reported for other amyloidogenic proteins. These polymorphic and ambidextrous characteristics of IAPP fibrils were conserved upon interfacing with EGCG (Figs. 3(f)-3(i) ), demonstrating the physical nature of the interaction. EGCG appeared more effective at IAPP amyloid inhibition than remodeling, corroborated by the increased distribution of curly aggregates at elevated EGCG-IAPP molar ratios (Fig. S3 in the ESM) . The comparable effects on IAPP fibrillization inhibition and remodeling by fresh, oxidized, or reduced EGCG were indicative of the significance of π-stacking, as hydrogen bonding and hydrophobic interactions were altered while aromatic EGCG moieties were conserved across the three cases. In light of the importance of π-stacking in peptide assembly and fibrillization inhibition and remodeling [12, 33] , exploiting this mode of interaction by molecular design may hold the key to effective peptide aggregation intervention.
It is plausible that mesoscopic properties of fibrils may have direct or indirect consequences on fibril cellular interactions, circulation, and pathology. Moreover, the insights gained from this study may prove beneficial not only to amyloidogenesis research but also to antibacterial strategies by remodeling functional amyloids [16, 37] to break down their communicative networks.
Methods
Materials
IAPP (37-residue sequence: KCNTATCATQRLANF-LVHSSNNFGAILSSTNVGSNTY; disulfide bridge: 2-7; M W : 3,906) was obtained as lyophilized powder from AnaSpec. EGCG (≥ 95%) and L-glutathione (≥ 98%) were acquired from Sigma-Aldrich. IAPP was weighed using a Cubis MSE balance (0.01 mg resolution; Sartorius), dissolved in water to a concentration of 100 μM (IAPP is known to fibrillate at micromolar concentrations in vitro), and used immediately for TEM sample preparations. Mature amyloids were generated after dissolving IAPP in water for one month. EGCG stock solutions (1 mM) were prepared immediately or 24 h prior to TEM sample preparation to obtain fresh or oxidized EGCG, respectively. Fresh EGCG solutions were colorless up until 6 h, while oxidized EGCG solutions appeared light yellow. Therefore, nominally fresh EGCG would have been partially auto-oxidized after 6 h. Reduced EGCG was obtained by mixing the polyphenol with GSH (1 mM stock) at a 1:1 molar ratio in water. All solutions were prepared using degassed ultrapure Milli-Q water (18.2 MΩ·cm; Millipore Corporation, USA).
Thioflavin T (ThT) assay
IAPP was mixed with ThT and fresh, oxidized, or reduced EGCG, to a final concentration of 25 μM, each. As control, ThT was mixed with EGCG derivatives without the addition of IAPP. Each sample (100 μL) was added to a 96-well plate (Costar black/clear bottom) and changes in ThT fluorescence (read from the bottom) were recorded every 5 min over 24 h at 25 °C using a FlexStation 3 Multi-Mode Microplate Reader (Molecular Devices; excitation: 440 nm, emission: 485 nm).
Transmission electron microscopy
The effects of EGCG on the formation and morphology of IAPP amyloids were investigated using highresolution TEM. To this end, solutions of IAPP or IAPP mixed with fresh, oxidized, or GSH-reduced EGCG were incubated at room temperature. All chemicals were used at a concentration of 50 μM and molar ratios of IAPP:EGCG species:GSH were kept at 1:1:1.
Approximately 4 μL of each sample solution after 20 min, 1 h, 6 h, and 24 h of incubation was pipetted onto glow discharged (15 s) copper grids (100 mesh; ProSciTech), followed by 60 s of adsorption. Excess samples were drawn off using filter papers, the grids were washed twice with Milli-Q water, and then the excess was drawn off again. The grids were stained with 2% uranyl acetate for 15 s, after which excess stain was drawn off and the grids air-dried. Imaging was performed with a Tecnai G2 F20 transmission electron microscope (FEI, Eindhoven, Netherlands), operating at a voltage of 200 kV. Images were recorded using a Gatan UltraScan 1,000 (2k × 2k) CCD camera (Gatan, California, USA) and Gatan Microscopy Suite control software.
Tracking and physical characterization of IAPP fibrils
Fibril tracking and analysis were performed with FiberApp software [27] to determine the effects of EGCG species on the mesoscopic parameters of λ, contour length (l), and periodicity (2p, where p is the pitch size) of IAPP fibrils. The FiberApp open source code was developed based on statistical polymer physics and enables structural analysis at the single molecular level of high-resolution imaging of fiberlike, filamentous, and macromolecular objects [27] . λ reflects rigidity, an intrinsic property of polymers, and is mathematically defined via the bond correlation function (BCF) in three-dimensional (3D) or twodimensional (2D) as the length over which angular correlations in the tangential direction decrease by a factor of e. Here, the λ values of IAPP fibrils were estimated using BCF, mean-squared end-to-end distance (MSED), and mean-squared midpoint displacement (MSMD; Figs. S5(a)-S5(f) in the ESM), and then presented as average values determined by the three methods ( Fig. S6(g ) in the ESM) [27] . Contour length corresponds to the end-to-end length of a polymer along its contour. In this study, 2p of a twisting fibril was determined by calculating the intensity autocorrelation function, while fibril thickness was analyzed by ImageJ (National Institutes of Health). Values of persistence length and contour length were obtained based on statistical analysis of 4,044 fibrils (Table S1 in the ESM). Nano Res. 2018, 11 (7): 3636-3647
Circular dichroism spectroscopy
Circular dichroism (CD) spectroscopy was utilized to provide insights into the effects of EGCG on the secondary structures of IAPP fibrils. We mixed IAPP (25 μM, final concentration) with fresh, oxidized, or reduced EGCG (25 μM, final concentration) and preincubated the samples for 24 h. CD spectra were taken using a Chirascan Plus qCD instrument (Applied Photophysics) at 0 and 24 h of incubation. Experiments were performed at 25 °C with a wavelength range of 190-260 nm.
Atomic force microscopy
A droplet of 20 μL of sample solution (50 μM each of IAPP and EGCG) was deposited and incubated for 2 min on freshly cleaved mica, rinsed with Milli-Q water, and then air-dried. Images were collected using a Nanoscope VIII Multimode Scanning Force Microscope (Bruker) operated in tapping mode in air. Images were flattened using the Nanoscope Analysis software (version 8.15) and no further image processing was made. Statistical analysis of fibrils was performed with the FiberApp software.
Discrete molecular dynamics simulations
DMD is a special type of molecular dynamics (MD) algorithm where continuous potentials are approximated by step-wise potential functions. A detailed description of the DMD algorithm has been previously provided [38, 39] . All molecules represented by the unitedatom model will all heavy atoms and polar hydrogen atoms explicitly modeled, and an implicit solvent model was used.
Step-wise potential functions were obtained by mimicking the continuous interatomic interaction potentials of the molecular mechanicsbased force field, the Medusa force field [40] . Following the same physical laws, dynamics in DMD are equivalent to continuous potential MD at timescales longer than picoseconds but with differences mainly within the short timescales of the sub-picosecond range (i.e., the average time step between two consecutive interatomic collisions where a potential energy step is encountered). Interatomic interactions included van der Waals, solvation, electrostatic interactions, and hydrogen bonds. Solvation energy was modeled after the Lazaridis-Karplus implicit solvent model, EEF1 [40] [41] [42] [43] . Distance-and angular-dependent hydrogen bond interactions were modeled using a reaction-like algorithm [41] . Screened electrostatic interactions were computed by the Debye-Hückel approximation. A Debye length of 1 nm was used by assuming a water dielectric constant of 80 and a monovalent electrolyte concentration of 0.1 M. The Andersen thermostat was used to maintain constant temperature [44] .
Small molecule ligands like EGCG were modeled in all-atom DMD simulations using the MedusaScore [41] , an extension of the Medusa force field [40] . The MedusaScore was parameterized using a large set of small molecule ligands [41] and was transferrable to different molecular systems. The predictive power of the MedusaScore was validated in various benchmark studies, including recent community structure-activity resource (CSAR) prediction exercises of blind ligandreceptor docking [45, 46] , where the MedusaScore performance was among the best approaches in predicting near-native ligand-binding poses and binding affinities.
We used the same experimental constraints as Tycko et. al. [32, 33] to construct the larger fibril models. In Model 1, side chains of Gln10, Leu12, Asn14, and Leu16 were located inwards to the β-sheet formed by residues [28-35, 37, 38] . Side chains of Arg11, Ala13, and Phe15 of the protofibril were buried to form the fibril. In Model 2, the residues mentioned above were positioned in the opposite direction. We used a central peptide from each of the two models, shared by the Tycko group, and applied translational and two-fold rotational symmetries to reconstruct the larger fibril. Using the same proximity constraints, we performed DMD simulations to relax the model structure until the system potential energies reached equilibrium at 300 K. A total of 20 EGCG monomers were used to maintain a 1:1 ratio between EGCG monomers and IAPP monomers in the fibril. IAPP peptides at both ends of the fibril (Fig. 4(e) , magenta) were expected to be more flexible than those inside the fibril (cyan). To reduce computational cost for such a large molecular system, we allowed the four terminal IAPPs to move freely. For the remaining 16 interior IAPP peptides, we constrained the corresponding β-sheet rich regions Nano Res. 2018, 11(7): 3636-3647 (residues 8-17 and 28-37) and allowed the rest of the unstructured loop regions to move freely.
Basic and acidic amino acids of IAPP (fibril) were assigned charges corresponding to their titration states at physiological conditions (pH = 7.4); Arg and Lys residues were assigned +1, Asp and Glu were assigned -1, while His was neutral. Counterions (Cl -) were added to maintain the net charge of the systems at zero and to account for possible counterion condensation [47] .
In simulations of EGCG binding with soluble IAPP peptides, the initial structure of the IAPP monomer was obtained from the Protein Data Bank (www.rcsb.org/pdb; PDB code: 2L86), and we used the EGCG structure obtained from PubChem (www.pubchem.ncbi.nlm.nih.gov; CID: 65064). The disulfide bond connecting C2 and C7 in each IAPP peptide was maintained during DMD simulations of both soluble IAPPs and amyloid fibrils. To keep the peptide concentration fixed during simulations of EGCG binding with various numbers of soluble IAPPs, we varied the size of a cubic simulation box with a dimension of 63.7 Å for one IAPP to 127.4 Å for eight peptides. For simulations of EGCG binding with the IAPP fibril, we used a cubic box with a dimension of 173 Å. The periodic boundary conditions were used for all simulations. For data analysis, we used an inter-atomic distance cutoff of 5 Å to define an atomic contact.
